TCR2 Therapeutics INC.
SEC CIK 1750019 · TCRR · last insider filing 2024-02-14
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gadicke Ansbert | Director | filed 2019 - 2023 |
| Allen Andrew R | Director | filed 2019 - 2023 |
| Webster Stephen W | Director | filed 2020 - 2023 |
| Gibson Neil W | Director | filed 2019 - 2023 |
| Menzel Garry E | Director · President and CEO | filed 2019 - 2023 |
| Tomasello Shawn | Director | filed 2021 - 2023 |
| Hoos Axel | Director | filed 2020 - 2023 |
| Hegde Priti | Director | filed 2021 - 2023 |
| Baeuerle Patrick | Director | filed 2019 - 2020 |
| Jovan-Embiricos Morana | Director | filed 2019 - 2019 |
| Finer Mitchell H. | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sullivan Eric | Chief Financial Officer | filed 2022 - 2023 |
| Justice Angela | Chief People Officer | filed 2020 - 2023 |
| Cardama Alfonso Quintas | Chief Medical Officer | filed 2019 - 2023 |
| Harrison Rosemary | Chief Business & Strategy | filed 2022 - 2023 |
| Olagunju Peter | Chief Technical Officer | filed 2021 - 2023 |
| Hofmeister Robert | Chief Scientific Officer | filed 2019 - 2021 |
| Somaiya Mayur Ian | Chief Financial Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.